You are here

Home » Content

TOTAL ATELEKTAZİ YAPMIŞ AKCİĞER KANSERLİ OLGULARDA EKSTERNAL RADYOTERAPİNİN PALYATİF ETKİSİNİN RETROSPEKTİF OLARAK DEĞERLENDİRİLMESİ

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2001

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
We evaluated the effect of radiation therapy in 27 patients with total atelectasis with lung cancer, between January 1980 and December 1996. The mean age of the patients was 56 years (31-87) of whom 26 were males. The patients were treated by primary radiation therapy, with doses ranging from 3000 to 6600 cGy. Initial symptoms included dyspnea in 24 (%88.8), cough in 22 (%81.4), hemoptysis in 5 (%18.5) and pain in 11 (%40.7) patients. The response of atelectasis to radiation therapy was established on the basis of follow–up chest roentgenograms. Follow-up was 1 to 24 months (median 6 months) Results.- Tweenty-seven patients with obstructive atelectasis were treated with external radiation therapy. Subjective response was achieved in %65 (17) of cases, objective response was %74 (20) of the cases. Dyspnea improved in %58.3, cough in % 54.3, hemoptysis in %80, pain in %54.5 of the patients. Twelve of 20 patients (%60), who had receive objective responses were treated with doses ranging from 5000-6600. Conclusion.- Radiotherapy is a feasible treatment modality of total atelectasis developed by means of lung cancer.
Bookmark/Search this post with
Abstract (Original Language): 
Büyük hava yollarının tümörle tıkanması sonucu oluşan atelektazi ve pnömoniler, akciğer fonksiyonlarının azalmasına ve olgularda ciddi solunum yetmezliği semptomlarının ortaya çıkmasına neden olmaktadır. Prognozu kötüleştiren bu durumun hızla tedavi edilmesi büyük önem taşımaktadır. Cerrahpaşa Tıp Fakültesi Radyasyon Onkolojisi Ana Bilim Dalı’mızda 1980-1996 yılları arasında 27 total atelektazi olgusuna palyatif eksternal radyoterapi uygulanmıştır. Olgulardaki toplam radyolojik yanıt %74 (20 olgu), toplam subjektif yanıt %65 (17 olgu) bulunmuştur. Radyoterapi sonunda öksürük şikayetinde %54.3, dispnede %58.3, hemoptizide %80, ağrıda %54.5 palyasyon sağlanmıştır. Sonuç olarak, eksternal radyoterapi, total atelektazili olgularda başarıyla uygulanabilen tedavi yöntemlerinden biridir.
FULL TEXT (PDF): 
PDF icon arastirmax-total-atelektazi-yapmis-akciger-kanserli-olgularda-eksternal-radyoterapinin-palyatif-etkisinin-retrospektif-olarak-degerlendirilmesi.pdf
  • 3
151-155
  • Turkish

REFERENCES

References: 

1. Minna JD, Higgins GA, Glatstein EJ. Cancer of
the Lung. Cancer principles and practice of
oncology. Ed: DeVita VT. 2. baskı. Philadelphia:
JB Lippincott co 1985; 518.
2. Mehta M, Petereit D, Chosy L, Harmon M,
Fowler J, Shahabi S, Thomadsen B, Kinsella T.
Sequential comparison of low dose rate and hyperfractionated
high dose rate endobronchial
radiation for malignant airway occlusion. Int J
Radiat Oncol Biol Phys 1992; 23: 133-139.
3. Macha HN, Loddenkemper R. Interventional
bronchoscopic procedure: endobronchial radiotherapy,
laser therapy and stent implantation.
In European Respiratory Monograph:Cancer of
the Lung. Ed: Spiro SG,ERS Journals Ltd,
Lund. 1995; 1: 332-360.
4. Chetty KG, Moran EM, Sassoon CS, Viravathone
T, Light RW. Effect of radiation therapy
on bronchial obstruction due to bronchogenic
carcinoma. Chest 1989; 95: 582-584.
5. Majid OA, Lee S, Khushalanı S, Seydel AG.
The response of atelectasis from lung cancer to
radiation therapy. Int Radiat Oncol Biol Phys
1986; 12: 231-232.
6. Reddy SP, Marks J.E. Total atelectasis of the
lung, secondary to malignant airway obstruction.
Am J. Clin Oncol 1990; 13: 394-400.
7. Slavson RG, Scott RM. Radiation therapy in
bronchogenic carcinoma . Radiology 1979; 132:
175-176.
8. Burt PA, O’Driscoll BR, Notley HM, Barber PV,
Stout R. Intraluminal irradiation for the palliation
of the lung cancer with the high dose rate
micro selectron.Thorax 1990; 45: 765-768.
9. Speiser BL, Spratling L. Remote afterloading
brachytherapy for the local control of endobronchial
carcinoma, in Brachytherapy from radium
to optimization. Ed. Mould RF, Battermann JJ,
Martinez AA, Speiser BL. Nucletron; Veenendaal,
1994; 180-195.
10. Tredaniel J, Hennequin C, Zalcman G, Walter
S, Homasson JP, Maflin C, Hirsch A. Prolonged
survival after HDR endobronchial radiation for
malignant airway obstruction. Chest 1994 ;
105; 3: 767-772.
11. Miller JI, Phillips TW. Neodymium-YAG laser
and brachytherapy in the management of inoperable
bronchogenic carcinoma. Ann Thorac
Surg 1990; 50: 190-196.

Thank you for copying data from http://www.arastirmax.com